Nasal insulin not effective for type 1 diabetes

Administering nasal insulin to children and infants who face strong risks of type 1 diabetes is not significant in preventing the disease from developing. The study will be published in the Lancet .
A research team at the University of Turku, Finland, analysed blood cord samples and entered some 264 high risk siblings into a trial of nasal insulin . The children were divided into insulin and placebo groups, and administering nasal insulin was found to not be effective in stopping the development of type 1 diabetes.
The authors reportedly commented: “Administration of nasal insulin did not delay or prevent type I diabetes in children with genetically conferred risk of disease, even when started soon after antibodies to the condition were detected.”